Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03342352
Title Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements No
Sponsors Incyte Corporation
Indications

hypopharynx cancer

oral squamous cell carcinoma

head and neck squamous cell carcinoma

laryngeal squamous cell carcinoma

oropharynx cancer

Therapies

Carboplatin + Cetuximab + Cisplatin + Fluorouracil

Carboplatin + Cisplatin + Epacadostat + Fluorouracil + Nivolumab

Carboplatin + Cisplatin + Fluorouracil + Nivolumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.